Hypothesis

19 Matching Annotations

Aug 2026
www.sciencedirect.com www.sciencedirect.com

Surface and global proteomics identify ROR2 and other proteins as potentially actionable immunotherapeutic targets in osteosarcoma

1
1. scibot 28 Aug 2026
  
  in Public
  
  RRID:CVCL_0439
  
  DOI: 10.1016/j.celrep.2026.117884
  
  Resource: (KCLB Cat# 21543, RRID:CVCL_0439)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_0439
  
  What is this?
  
  RRID:CVCL_0439
Visit annotations in context

Tags

RRID:CVCL_0439

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2211124726009629
www.sciencedirect.com www.sciencedirect.com

Biomimetic multistage drug delivery system for reversing chemoresistance in osteosarcoma

1
1. scibot 01 Aug 2026
  
  in Public
  
  CVCL_0439
  
  DOI: 10.1016/j.cej.2026.180066
  
  Resource: (KCLB Cat# 21543, RRID:CVCL_0439)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_0439
  
  What is this?
  
  RRID:CVCL_0439
Visit annotations in context

Tags

RRID:CVCL_0439

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1385894726075273
Jul 2026
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Prognostic characteristics of disulfidptosis-related genes across cancers and their potential implications in osteosarcoma

1
1. scibot 03 Jul 2026
  
  in Public
  
  RRID:CVCL_0439
  
  DOI: 10.1177/00368504261464856
  
  Resource: (KCLB Cat# 21543, RRID:CVCL_0439)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_0439
  
  What is this?
  
  RRID:CVCL_0439
Visit annotations in context

Tags

RRID:CVCL_0439

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC13319833/
May 2026
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

TENT5A Maintains MYC mRNA Stability to Enhance Osteosarcoma Stemness

1
1. scibot 06 May 2026
  
  in Public
  
  CVCL_0439
  
  DOI: 10.1158/0008-5472.CAN-25-4635
  
  Resource: (KCLB Cat# 21543, RRID:CVCL_0439)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_0439
  
  What is this?
  
  RRID:CVCL_0439
Visit annotations in context

Tags

RRID:CVCL_0439

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC13136882/
Feb 2026
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

MAT2A enhances PARN transcription via SRF to accelerate glycolysis and drive malignant progression in osteosarcoma

1
1. scibot 20 Feb 2026
  
  in Public
  
  RRID: CVCL_0439
  
  DOI: 10.1038/s42003-026-09518-w
  
  Resource: (KCLB Cat# 21543, RRID:CVCL_0439)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_0439
  
  What is this?
  
  RRID:CVCL_0439
Visit annotations in context

Tags

RRID:CVCL_0439

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC12905121/
Jan 2026
advanced.onlinelibrary.wiley.com advanced.onlinelibrary.wiley.com

Tumor Extracellular Vesicles lncOSLMT Drives Lung Inflammatory Premetastatic Niche Formation in Osteosarcoma via m6A-Dependent hnRNPA2B1/COX-2 Axis

1
1. scibot 23 Jan 2026
  
  in Public
  
  RRID:CVCL_0439
  
  DOI: 10.1002/advs.202519490
  
  Resource: (KCLB Cat# 21543, RRID:CVCL_0439)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_0439
  
  What is this?
  
  RRID:CVCL_0439
Visit annotations in context

Tags

RRID:CVCL_0439

Annotators

scibot

URL

advanced.onlinelibrary.wiley.com/doi/10.1002/advs.202519490
Jul 2025
www.sciencedirect.com www.sciencedirect.com

Human osteosarcoma cell secretome impairs neonatal mouse calvarial osteogenic cells functions and modifies the nanoparticles-derived protein profile

1
1. scibot 15 Jul 2025
  
  in Public
  
  RRID:CVCL_0439
  
  DOI: 10.1016/j.lfs.2025.123837
  
  Resource: (KCLB Cat# 21543, RRID:CVCL_0439)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_0439
  
  What is this?
  
  RRID:CVCL_0439
Visit annotations in context

Tags

RRID:CVCL_0439

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S0024320525004722
Feb 2025
www.sciencedirect.com www.sciencedirect.com

Methionine intervention induces PD-L1 expression to enhance the immune checkpoint therapy response in MTAP-deleted osteosarcoma

1
1. scibot 21 Feb 2025
  
  in Public
  
  ATCCCat#CRL-1547
  
  DOI: 10.1016/j.xcrm.2025.101977
  
  Resource: (KCLB Cat# 21543, RRID:CVCL_0439)
  
  Curator: @areedewitt04
  
  SciCrunch record: RRID:CVCL_0439
  
  What is this?
  
  RRID:CVCL_0439
Visit annotations in context

Tags

RRID:CVCL_0439

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379125000503
Jan 2025
febs.onlinelibrary.wiley.com febs.onlinelibrary.wiley.com

FEBS Press

1
1. scibot 25 Jan 2025
  
  in Public
  
  CVCL_0439
  
  DOI: 10.1111/febs.17375
  
  Resource: (KCLB Cat# 21543, RRID:CVCL_0439)
  
  Curator: @inessasarian
  
  SciCrunch record: RRID:CVCL_0439
  
  What is this?
  
  RRID:CVCL_0439
Visit annotations in context

Tags

RRID:CVCL_0439

Annotators

scibot

URL

febs.onlinelibrary.wiley.com/doi/10.1111/febs.17375
Aug 2024
www.cell.com www.cell.com

Tumor mitochondrial oxidative phosphorylation stimulated by the nuclear receptor RORγ represents an effective therapeutic opportunity in osteosarcoma

1
1. scibot 13 Aug 2024
  
  in Public
  
  CRL-1547
  
  DOI: 10.14309/01.ajg.0000966496.32906.2f
  
  Resource: (KCLB Cat# 21543, RRID:CVCL_0439)
  
  Curator: @AniH
  
  SciCrunch record: RRID:CVCL_0439
  
  What is this?
  
  RRID:CVCL_0439
Visit annotations in context

Tags

RRID:CVCL_0439

Annotators

scibot

URL

cell.com/cell-reports-medicine/fulltext/S2666-3791(24)00188-5
Jan 2024
onlinelibrary.wiley.com onlinelibrary.wiley.com

Augmented drug resistance of osteosarcoma cells within decalcified bone matrix scaffold: The role of glutamine metabolism

1
1. scibot 18 Jan 2024
  
  in Public
  
  RRID: CVCL_0439
  
  DOI: 10.1002/ijc.34841
  
  Resource: (KCLB Cat# 21543, RRID:CVCL_0439)
  
  Curator: @anisehay
  
  SciCrunch record: RRID:CVCL_0439
  
  What is this?
  
  RRID:CVCL_0439
Visit annotations in context

Tags

RRID:CVCL_0439

Annotators

scibot

URL

onlinelibrary.wiley.com/doi/10.1002/ijc.34841
Jan 2023
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Targeting Podoplanin for the Treatment of Osteosarcoma

1
1. scibot 12 Jan 2023
  
  in Public
  
  CVCL_0439
  
  DOI: 10.1158/1078-0432.CCR-21-4509
  
  Resource: (KCLB Cat# 21543, RRID:CVCL_0439)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_0439
  
  What is this?
  
  RRID:CVCL_0439
Visit annotations in context

Tags

RRID:CVCL_0439

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC9359727/
Dec 2022
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Effects of osteoblast-derived extracellular vesicles on aggressiveness, redox status and mitochondrial bioenergetics of MNNG/HOS osteosarcoma cells

1
1. scibot 31 Dec 2022
  
  in Public
  
  CVCL_0439
  
  DOI: 10.3389/fonc.2022.983254
  
  Resource: (KCLB Cat# 21543, RRID:CVCL_0439)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_0439
  
  What is this?
  
  RRID:CVCL_0439
Visit annotations in context

Tags

RRID:CVCL_0439

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC9762506/
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Vascular Niche Facilitates Acquired Drug Resistance to c-Met Inhibitor in Originally Sensitive Osteosarcoma Cells

1
1. scibot 31 Dec 2022
  
  in Public
  
  RRID:CVCL_0439
  
  DOI: 10.3390/cancers14246201
  
  Resource: (KCLB Cat# 21543, RRID:CVCL_0439)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_0439
  
  What is this?
  
  RRID:CVCL_0439
Visit annotations in context

Tags

RRID:CVCL_0439

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC9776923/
Jul 2022
www.sciencedirect.com www.sciencedirect.com

METTL14-mediated epitranscriptome modification of MN1 mRNA promote tumorigenicity and all-trans-retinoic acid resistance in osteosarcoma

1
1. scibot 08 Jul 2022
  
  in Public
  
  RRID:CVCL_0439
  
  DOI: 10.1016/j.ebiom.2022.104142
  
  Resource: (KCLB Cat# 21543, RRID:CVCL_0439)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_0439
  
  What is this?
  
  RRID:CVCL_0439
Visit annotations in context

Tags

RRID:CVCL_0439

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2352396422003231
Aug 2021
onlinelibrary.wiley.com onlinelibrary.wiley.com

Untitled document

1
1. scibot 08 Aug 2021
  
  in Public
  
  RRID:CVCL_0439
  
  DOI: 10.1002/jcp.26330
  
  Resource: (KCLB Cat# 21543, RRID:CVCL_0439)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_0439
  
  What is this?
  
  RRID:CVCL_0439
Visit annotations in context

Tags

RRID:CVCL_0439

Annotators

scibot

URL

onlinelibrary.wiley.com/doi/10.1002/jcp.26330/full
Jul 2021
onlinelibrary.wiley.com onlinelibrary.wiley.com

Novel smoothened antagonists as anti‐neoplastic agents for the treatment of osteosarcoma

1
1. scibot 30 Jul 2021
  
  in Public
  
  RRID:CVCL_0439
  
  DOI: 10.1002/jcp.26330
  
  Resource: (KCLB Cat# 21543, RRID:CVCL_0439)
  
  Curator: @anp055
  
  SciCrunch record: RRID:CVCL_0439
  
  What is this?
  
  RRIDCUR:Validated RRID:CVCL_0439
Visit annotations in context

Tags

RRIDCUR:Validated

RRID:CVCL_0439

Annotators

scibot

URL

onlinelibrary.wiley.com/doi/full/10.1002/jcp.26330
Jan 2021
www.sciencedirect.com www.sciencedirect.com

Metabolic compensation activates pro-survival mTORC1 signaling upon 3-phosphoglycerate dehydrogenase inhibition in osteosarcoma

1
1. scibot 28 Jan 2021
  
  in Public
  
  RRID:CVCL_0439
  
  DOI: 10.1016/j.celrep.2020.108678
  
  Resource: (KCLB Cat# 21543, RRID:CVCL_0439)
  
  Curator: @Naa003
  
  SciCrunch record: RRID:CVCL_0439
  
  What is this?
  
  RRIDCUR:Validated RRID:CVCL_0439
Visit annotations in context

Tags

RRIDCUR:Validated

RRID:CVCL_0439

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2211124720316673
Jan 2020
onlinelibrary.wiley.com onlinelibrary.wiley.com

Mycophenolic Acid is a Drug with the Potential to be Repurposed for Suppressing Tumour Growth and Metastasis in Osteosarcoma Treatment

1
1. scibot 13 Jan 2020
  
  in Public
  
  RRID:CVCL_0439
  
  DOI: 10.1002/ijc.32735
  
  Resource: (KCLB Cat# 21543, RRID:CVCL_0439)
  
  Curator: @Naa003
  
  SciCrunch record: RRID:CVCL_0439
  
  What is this?
  
  RRID:CVCL_0439 RRIDCUR:Validated
Visit annotations in context

Tags

RRIDCUR:Validated

RRID:CVCL_0439

Annotators

scibot

URL

onlinelibrary.wiley.com/doi/full/10.1002/ijc.32735